220 related articles for article (PubMed ID: 23582915)
21. Gastric neuroendocrine tumours.
Crosby DA; Donohoe CL; Fitzgerald L; Muldoon C; Hayes B; O'Toole D; Reynolds JV
Dig Surg; 2012; 29(4):331-48. PubMed ID: 23075625
[TBL] [Abstract][Full Text] [Related]
22. [The coexistence of 2 different neuroendocrine tumors of the upper gastrointestinal tract and pancreas].
Reusch J; Keck AM; Link KH; Mohr HH
Dtsch Med Wochenschr; 1998 Dec; 123(49):1472-7. PubMed ID: 9861888
[TBL] [Abstract][Full Text] [Related]
23. Gastric neuroendocrine neoplasms: A review.
Köseoğlu H; Duzenli T; Sezikli M
World J Clin Cases; 2021 Sep; 9(27):7973-7985. PubMed ID: 34621854
[TBL] [Abstract][Full Text] [Related]
24. Neuroendocrine Tumors of the Stomach.
Corey B; Chen H
Surg Clin North Am; 2017 Apr; 97(2):333-343. PubMed ID: 28325190
[TBL] [Abstract][Full Text] [Related]
25. Neuroendocrine neoplasms of the stomach.
Louthan O
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):455-60. PubMed ID: 23817299
[TBL] [Abstract][Full Text] [Related]
26. Gastric neuroendocrine tumors.
Delle Fave G; Capurso G; Annibale B; Panzuto F
Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
[TBL] [Abstract][Full Text] [Related]
27. Comparison study of gastrinomas between gastric and non-gastric origins.
Huang SF; Kuo IM; Lee CW; Pan KT; Chen TC; Lin CJ; Hwang TL; Yu MC
World J Surg Oncol; 2015 Jun; 13():202. PubMed ID: 26077245
[TBL] [Abstract][Full Text] [Related]
28. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
Lee HE; Mounajjed T; Erickson LA; Wu TT
Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are.
Rossi RE; Elvevi A; Gallo C; Palermo A; Invernizzi P; Massironi S
World J Gastroenterol; 2022 Jul; 28(26):3258-3273. PubMed ID: 36051341
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).
Kos-Kudła B; Blicharz-Dorniak J; Handkiewicz-Junak D; Jarząb B; Jarząb M; Kunikowska J; Kuśnierz K; Król R; Królicki L; Krzakowski M; Nasierowska-Guttmejer A; Nowakowska-Duława E; Patkowski W; Szawłowski AW; ;
Endokrynol Pol; 2013; 64(6):418-43. PubMed ID: 24431116
[TBL] [Abstract][Full Text] [Related]
31. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
[TBL] [Abstract][Full Text] [Related]
32. [Current opinions on pathogenesis, diagnostic procedures and management of gastric neuroendocrine tumors].
Gilis-Januszewska A; Baczyńska E; Szybiński P; Sowa-Staszczak A; Trofimiuk M; Pach D; Tomaszewska R; Hubalewska-Dydejczyk A
Przegl Lek; 2009; 66(12):1052-61. PubMed ID: 20514905
[TBL] [Abstract][Full Text] [Related]
33. Endoscopy and Endoscopic Ultrasound in Assessing and Managing Neuroendocrine Neoplasms.
O'Toole D; Palazzo L
Front Horm Res; 2015; 44():88-103. PubMed ID: 26303706
[TBL] [Abstract][Full Text] [Related]
34. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3.
Panzuto F; Ramage J; Pritchard DM; van Velthuysen MF; Schrader J; Begum N; Sundin A; Falconi M; O'Toole D
J Neuroendocrinol; 2023 Aug; 35(8):e13306. PubMed ID: 37401795
[TBL] [Abstract][Full Text] [Related]
35. Management of Gastric Neuroendocrine Tumors: A Review.
Sok C; Ajay PS; Tsagkalidis V; Kooby DA; Shah MM
Ann Surg Oncol; 2024 Mar; 31(3):1509-1518. PubMed ID: 38062290
[TBL] [Abstract][Full Text] [Related]
36. Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours.
Murugesan SV; Steele IA; Dimaline R; Poston GJ; Shrotri M; Campbell F; Varro A; Pritchard DM
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):474-81. PubMed ID: 23249603
[TBL] [Abstract][Full Text] [Related]
37. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
[TBL] [Abstract][Full Text] [Related]
38. New Developments in Gastric Neuroendocrine Neoplasms.
Exarchou K; Stephens NA; Moore AR; Howes NR; Pritchard DM
Curr Oncol Rep; 2022 Jan; 24(1):77-88. PubMed ID: 35059996
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine tumours of the duodenum. Clinical aspects, pathomorphology and therapy.
Witzigmann H; Loracher C; Geissler F; Wagner T; Tannapfel A; Uhlmann D; Caca K; Hauss J; Hehl JA
Langenbecks Arch Surg; 2002 Jan; 386(7):525-33. PubMed ID: 11819111
[TBL] [Abstract][Full Text] [Related]
40. Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis.
Chen WC; Warner RRP; Harpaz N; Zhu H; Roayaie S; Kim MK
Pancreas; 2019 Jan; 48(1):131-134. PubMed ID: 30531243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
